Drugs / aminopterin

Trials 4 · a red edge is where a trial was stopped

1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03431974 Nov 2018 → Jan 2021 psoriasis Syntrix Biosystems, Inc. Completed No outcome recorded
Phase 2 NCT00176462 Feb 2001 → Sep 2008 acute lymphoblastic leukemia Rutgers, The State University of New Jersey Completed No outcome recorded
Phase 2 NCT00003821 Jan 1998 → ? endometrial cancer Genzyme, a Sanofi Company Withdrawn No outcome recorded
Phase 2 NCT00003305 Jul 1997 → Sep 2007 leukemia Genzyme, a Sanofi Company Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00937027 Comparator Jun 2009 → Apr 2010 psoriasis Syntrix Biosystems, Inc. Completed No outcome recorded

Evidence & citations 18 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as Aminopterin ClinicalTrials.gov intervention name — accepted as the source's own label NCT03431974
4

NCT00176462

NCT00003821

NCT00937027

NCT00003305

Known as 4-amino-pga ChEMBL registry synonym — accepted as the source's own label CHEMBL376180
Known as 4-aminofolic acid ChEMBL registry synonym — accepted as the source's own label CHEMBL376180
Known as 4-aminopteroic acid ChEMBL registry synonym — accepted as the source's own label CHEMBL376180
Known as AMINOPTERIN SODIUM ChEMBL registry synonym — accepted as the source's own label CHEMBL376180
Known as Aminopterina de sodio ChEMBL registry synonym — accepted as the source's own label CHEMBL376180
Known as Aminopterine sodique ChEMBL registry synonym — accepted as the source's own label CHEMBL376180
Known as Aminopteroylglutamic acid ChEMBL registry synonym — accepted as the source's own label CHEMBL376180
Known as Aminotrexate ChEMBL registry synonym — accepted as the source's own label CHEMBL376180
Known as AMT “N-[4-[[(2,4-diamino-6-pterdinyl)methyl]amino]benzoyl]-L/D-glutamic acid (L/D-AMT) is an investigational drug in phase 1 clinical development that consists of the L-and...” PMID 22653877 May 2012
1

“LD-aminopterin (AMT) (3 mg (six 0.5 mg tablets).” NCT03431974

Known as L/D-AMT “N-[4-[[(2,4-diamino-6-pterdinyl)methyl]amino]benzoyl]-L/D-glutamic acid (L/D-AMT) is an investigational drug in phase 1 clinical development that consists of the L-and...” PMID 22653877 May 2012
Known as LD-Aminopterin LD-Aminopterin tablets (0.5 mg tablet) over-encapsulated, 3.0 mg (6 tablets) once orally each week for 14 weeks (14 doses).” NCT03431974
Known as Methotrexate related compound b ChEMBL registry synonym — accepted as the source's own label CHEMBL376180
Known as NSC-257456 ChEMBL registry synonym — accepted as the source's own label CHEMBL376180
Known as NSC-739 ChEMBL registry synonym — accepted as the source's own label CHEMBL376180
Modality Small molecule CHEMBL376180
Route Intravenous “Aminopterin is administered intravenously over 20 minutes for the first, second, and fourth doses, and orally for the third dose.” NCT00003305
Route Oral “Aminopterin is administered intravenously over 20 minutes for the first, second, and fourth doses, and orally for the third dose.” NCT00003305